Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.

Research has established links between the gut microbiome (GM) and both obesity and type 2 diabetes (T2D), which is much discussed, but underexplored. This study employed body mass index (BMI) as the ...

Apr. 8, 2025 — New research has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetes -- not the presence of certain fats, but their suppression. The study ...

Individuals with obesity or diabetes tend to concentrate on blood sugar or weight control, yet the liver is one of the most ...

During the time period 2020 to 2023, approximately 1 in 5 youth and 1 in 3 adults with type 1 diabetes and severe obesity ...

Scientists from Western University in Canada have discovered that a natural substance found in sweet oranges and tangerines ...

With American Diabetes Alert Day approaching on March 25, 2025, the Molly Diabetes Education and Management Center for Adults and Children urges individuals, especially those struggling with ...

3 Overall, increased rates of complications were reported in several of the studies that included patients with obesity and/or diabetes. No increase in complications in patients who were smokers ...

Adverse pregnancy outcomes (APOs) mediate a small proportion of the association between prepregnancy obesity and cardiovascular disease (CVD) risk in midlife.